Form D — ELIXIRGEN THERAPEUTICS, INC.
0001744333-25-000001 · filed 2025-02-12
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $600,000
- Total sold
- $600,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ELIXIRGEN THERAPEUTICS, INC.
- CIK
- 1744333
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 855 N. WOLFE ST.
BALTIMORE, MD 21205 - Phone
- 443-451-5300
Related persons
-
AKIHIRO KO · Executive OfficerBALTIMORE, MD
-
HIROAKI KOBAYASHI · DirectorBALTIMORE, MD
-
MINORU KO · DirectorBALTIMORE, MD
-
THOMAS WHITE · DirectorBALTIMORE, MD
-
SHAUNA CALLAHAN · DirectorBALTIMORE, MD
-
JEFFREY CLELAND · DirectorBALTIMORE, MD
View original on SEC EDGAR.